Genetic Variant Linked to Liver Transplant Outcomes

Researchers identified a donor genetic variant that correlates with higher risks for liver graft loss and reduced survival.

Updated on Oct. 14, 2026 in Life Sciences

A small glass medical vial holding a tissue sample rests on a clean stainless steel laboratory surface.
Researchers have identified a specific genetic variant in organ donors that correlates with increased risk of liver graft loss and reduced transplant survival. AI Illustration. Upload story photo >

Live Poll

Should medical research into genetic variants influence clinical transplantation protocols?

Scientists have identified that the donor rs2204985*GG genetic variant is linked to lower survival rates and an increased risk of graft loss in liver transplant patients. This discovery highlights a specific biological factor influencing outcomes following liver surgery.

Why it matters

Identifying genetic predictors for organ rejection and survival helps clinicians better understand transplant risks. This insight may eventually improve donor matching protocols by incorporating specific genetic markers into patient assessments.

The study analyzed 666 liver and 1,025 kidney transplants in Finland, validated by a Dutch cohort of 618 liver transplants using adjusted logistic regression and Cox models. The donor GG genotype showed no association with kidney transplant outcomes.

The details

Researchers utilized statistical modeling to determine that the rs2204985*GG variant is specifically associated with liver transplantation risks rather than kidney outcomes. Findings from the Finnish study were cross-referenced with Dutch data, revealing an odds ratio of 1.47 for graft loss in the Dutch cohort.

Timeline

  1. October 14, 2026: The research findings were formally published.

The Big Picture

This research contributes to the ongoing study of donor-recipient genetic compatibility in solid organ transplantation. The identification of the rs2204985*GG variant marks a shift in how surgeons and immunologists evaluate donor-specific risks for liver procedures.

These findings could eventually lead to more personalized donor matching processes to improve long-term survival for transplant recipients. While currently restricted to research settings, such genetic screening may become standard in clinical pre-transplant evaluations.

The takeaway

Understanding donor genetics provides a critical tool for medical professionals to predict post-operative transplant performance. Patients should discuss potential genetic risk factors and their implications with their specialized transplant medical team.

Further reading

For more on the intersection of genetics and medicine, explore our Life Sciences section.

Source note: This article includes information reported by Nature.

Live Poll

Should medical research into genetic variants influence clinical transplantation protocols?